Celgene Apprenti Contrôle de Gestion et Analyses (H/F) in Paris, France

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

Nous recherchons un(e) étudiant(e) en alternance pour une mission en Contrôle de Gestion et Analyses au sein de notre département Finance & Business Solutions, pour la rentrée scolaire 2018.

Missions :

Rattaché(e) au Responsable Financier de la filiale France vous serez amené(e) à participer aux principales activités relatives au suivi d’activité d’une filiale d’entreprise internationale :

  • L’analyse quotidienne des ventes,

  • La réalisation d’analyses d’activité,

  • La mise en place d’outils de reporting et d’indicateurs clés (finance, service clients, market insights),

  • Les révisions budgétaires,

  • Participation à des contrôles internes, mise en place des plans d’action associés / mise à jour et amélioration de nos process,

  • De manière ponctuelle, vous pourrez être impliqué dans d’autres projets du département

Vous aurez l’opportunité de collaborer avec différents services de l’entreprise au sein d’une équipe engagée et dynamique !

Profil et compétences recherchés :

Etudiant en école de commerce (Bac +4/+5) avec spécialisation finance

Capacités d’analyse et de synthèse

Rigueur et fiabilité

Bon relationnel

Bon niveau d’anglais, maîtrise du Pack Office Microsoft ®

Modalités d’apprentissage :

  • Accès au restaurant d’entreprise

  • Remboursement de 50% du titre de transport Ile de France

  • Poste basé à La Défense

#LI-POST

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE